These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8432786)

  • 1. Comparison of plasma androgen glucuronide levels after percutaneous or peroral androgen treatment in men: evidence for important splanchnic contribution to plasma 17 beta-hydroxyandrogen glucuronides.
    Giagulli VA; Verdonck L; Deslypere JP; Giorgino R; Vermeulen A
    J Clin Endocrinol Metab; 1993 Feb; 76(2):429-31. PubMed ID: 8432786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
    Anderson RA; Wallace AM; Wu FC
    J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Origin of plasma androstanediol glucuronide in men.
    Moghissi E; Ablan F; Horton R
    J Clin Endocrinol Metab; 1984 Sep; 59(3):417-21. PubMed ID: 6746859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of dihydrotestosterone to 5 alpha-androstane-3 alpha, 17 beta-diol glucuronide is greater in the peripheral compartment than in the splanchnic compartment.
    Duffy DM; Legro RS; Chang L; Stanczyk FZ; Lobo RA
    Fertil Steril; 1995 Oct; 64(4):736-9. PubMed ID: 7672144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the origin of androstanediol and androstanediol glucuronide in young and elderly men.
    Morimoto I; Edmiston A; Hawks D; Horton R
    J Clin Endocrinol Metab; 1981 Apr; 52(4):772-8. PubMed ID: 7204542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of C19 steroid glucuronides in pre-menopausal women with non-classical congenital adrenal hyperplasia.
    Whorwood CB; Ueshiba H; del Blazo P
    J Steroid Biochem Mol Biol; 1992 Apr; 42(2):211-21. PubMed ID: 1314640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetics of three doses of percutaneous dihydrotestosterone gel in healthy elderly men--a clinical research center study.
    Wang C; Iranmanesh A; Berman N; McDonald V; Steiner B; Ziel F; Faulkner SM; Dudley RE; Veldhuis JD; Swerdloff RS
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2749-57. PubMed ID: 9709942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
    Labrie F; Bélanger A; Cusan L; Candas B
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of 3 alpha-androstanediol glucuronide in human genital skin.
    Lobo RA; Paul WL; Gentzschein E; Serafini PC; Catalino JA; Paulson RJ; Horton R
    J Clin Endocrinol Metab; 1987 Oct; 65(4):711-4. PubMed ID: 3654916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased urinary 5 alpha-androstane-3 alpha,17 beta-diol glucuronide excretion in patients with benign prostatic hyperplasia.
    Wright F; Poizat R; Bongini M; Bozzolan F; Doukani A; Mauvais-Jarvis P
    J Clin Endocrinol Metab; 1985 Feb; 60(2):294-8. PubMed ID: 2578133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precursors of plasma androstanediol- and androgen-glucuronides in women.
    Giagulli VA; Verdonck L; Giorgino R; Vermeulen A
    J Steroid Biochem; 1989 Nov; 33(5):935-40. PubMed ID: 2532273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer.
    Stanczyk FZ; Azen CG; Pike MC
    J Steroid Biochem Mol Biol; 2013 Nov; 138():10-6. PubMed ID: 23474436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism.
    Horton R; Hawks D; Lobo R
    J Clin Invest; 1982 May; 69(5):1203-6. PubMed ID: 7068855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal testosterone therapy in the treatment of male hypogonadism.
    Ahmed SR; Boucher AE; Manni A; Santen RJ; Bartholomew M; Demers LM
    J Clin Endocrinol Metab; 1988 Mar; 66(3):546-51. PubMed ID: 3350906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma 3 alpha-androstanediol glucuronide in precocious adrenarche.
    Balducci R; Finocchi G; Mangiantini A; Bianchi P; Guglielmi R; Toscano V
    J Endocrinol Invest; 1993 Feb; 16(2):117-21. PubMed ID: 8463546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which testosterone replacement therapy?
    Cantrill JA; Dewis P; Large DM; Newman M; Anderson DC
    Clin Endocrinol (Oxf); 1984 Aug; 21(2):97-107. PubMed ID: 6467640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men.
    Blouin K; Richard C; Brochu G; Hould FS; Lebel S; Marceau S; Biron S; Luu-The V; Tchernof A
    J Endocrinol; 2006 Dec; 191(3):637-49. PubMed ID: 17170221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of plasma steroid glucuronides in intact and castrated men with prostatic cancer.
    Bélanger A; Brochu M; Cliche J
    J Clin Endocrinol Metab; 1986 May; 62(5):812-5. PubMed ID: 2937801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiopathology of plasma androstanediol-glucuronide.
    Vermeulen A; Giagulli VA
    J Steroid Biochem Mol Biol; 1991 Nov; 39(5B):829-33. PubMed ID: 1835405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct conversion of testosterone to dihydrotestosterone glucuronide in man.
    Ishimaru T; Edmiston A; Pages L; Horton R
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1282-6. PubMed ID: 263350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.